The management team at the Boston and Rolle-based firm will host the discussion starting at 8:00 a.m. EDT, which corresponds to 2:00 p.m. CET. Investors and analysts can access the live audio stream through the company’s investor relations portal. A replay of the call will be published on the same platform shortly after the session concludes.
SOPHiA GENETICS, which trades under the ticker SOPH, maintains its focus on AI-native healthcare technology. The company’s primary offering, the SOPHiA DDM platform, processes complex genomic and multimodal data to assist hospitals, laboratories, and biopharma institutions in refining patient care strategies.
Comments (0)
No comments yet. Be the first!